AP737A - New cryptophycins from synthesis. - Google Patents
New cryptophycins from synthesis. Download PDFInfo
- Publication number
- AP737A AP737A APAP/P/1997/001069A AP9701069A AP737A AP 737 A AP737 A AP 737A AP 9701069 A AP9701069 A AP 9701069A AP 737 A AP737 A AP 737A
- Authority
- AP
- ARIPO
- Prior art keywords
- taken together
- group
- methyl
- compound
- double bond
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D273/00—Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups C07D261/00 - C07D271/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Urology & Nephrology (AREA)
- Epidemiology (AREA)
- Endocrinology (AREA)
- Pulmonology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychology (AREA)
- Hematology (AREA)
- Reproductive Health (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Epoxy Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/400,057 US6013626A (en) | 1993-12-21 | 1995-03-07 | Cryptophycins from synthesis |
US08/482,141 US5952298A (en) | 1993-12-21 | 1995-06-07 | Cryptophycins |
PCT/US1996/003246 WO1996040184A1 (en) | 1995-03-07 | 1996-03-07 | New cryptophycins from synthesis |
Publications (2)
Publication Number | Publication Date |
---|---|
AP9701069A0 AP9701069A0 (en) | 1997-10-30 |
AP737A true AP737A (en) | 1999-03-15 |
Family
ID=27016884
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
APAP/P/1997/001069A AP737A (en) | 1995-03-07 | 1996-03-07 | New cryptophycins from synthesis. |
Country Status (23)
Country | Link |
---|---|
EP (1) | EP0830136B1 (zh) |
JP (1) | JP4181632B2 (zh) |
CN (1) | CN1165337C (zh) |
AP (1) | AP737A (zh) |
AT (1) | ATE279935T1 (zh) |
AU (1) | AU723652B2 (zh) |
BG (1) | BG63289B1 (zh) |
CZ (1) | CZ278197A3 (zh) |
DE (1) | DE69633667T2 (zh) |
ES (1) | ES2230561T3 (zh) |
FI (1) | FI973591A0 (zh) |
GE (1) | GEP20002206B (zh) |
HK (1) | HK1009747A1 (zh) |
HU (1) | HU225041B1 (zh) |
MD (1) | MD2196B2 (zh) |
NO (1) | NO326685B1 (zh) |
NZ (1) | NZ305571A (zh) |
OA (1) | OA10614A (zh) |
PL (1) | PL185949B1 (zh) |
RO (1) | RO118931B1 (zh) |
SK (1) | SK119997A3 (zh) |
TJ (1) | TJ347B (zh) |
WO (1) | WO1996040184A1 (zh) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997007798A1 (en) * | 1995-08-30 | 1997-03-06 | Eli Lilly And Company | Pharmaceutical compounds |
DE69736067T9 (de) * | 1996-08-30 | 2007-10-31 | University Of Hawaii, Honolulu | Neue cryptophycin-derivate als antineoplastika |
US6680311B1 (en) | 1996-08-30 | 2004-01-20 | Eli Lilly And Company | Cryptophycin compounds |
US5977387A (en) * | 1996-08-30 | 1999-11-02 | Eli Lilly And Company | Process for preparing pharmaceutical compounds |
AU4182197A (en) * | 1996-09-06 | 1998-03-26 | Eli Lilly And Company | Process to prepare pharmaceutical compounds |
WO1998009955A1 (en) * | 1996-09-06 | 1998-03-12 | Eli Lilly And Company | Process and novel intermediates |
CA2264527A1 (en) * | 1996-09-06 | 1998-03-12 | Eric David Moher | Process to prepare pharmaceutical compounds |
AU6338698A (en) * | 1997-02-26 | 1998-09-18 | Eli Lilly And Company | Tripeptide and tetrapeptide pharmaceutical compounds |
EP0861838A3 (en) * | 1997-02-26 | 1998-12-09 | Eli Lilly And Company | Process and intermediates for preparing cryptophycin compounds |
EP0870510A3 (en) * | 1997-04-11 | 1999-09-15 | Eli Lilly And Company | Synergistic combination comprising cryptophycin derivatives and microtubule synergizing agents |
EP0870501A1 (en) * | 1997-04-11 | 1998-10-14 | Eli Lilly And Company | Use of specific cryptophycin derivatives for the manufacture of a medicament in the treatment of fungal infections |
EP0870506A1 (en) * | 1997-04-11 | 1998-10-14 | Eli Lilly And Company | Compositions comprising a cryptophycin compound in combination with a synchronizing or activating agent for treating cancer |
JP2002527509A (ja) * | 1998-10-16 | 2002-08-27 | イーライ・リリー・アンド・カンパニー | 抗腫瘍剤を製造するための立体選択的な方法 |
US6376230B1 (en) | 1998-10-16 | 2002-04-23 | Eli Lilly And Company | Stereoselective process for producing intermediates of cryptophycins |
US6103913A (en) * | 1998-10-16 | 2000-08-15 | Eli Lilly And Company | Process for preparing enollactone derivatives |
WO2000034252A2 (en) * | 1998-12-07 | 2000-06-15 | Eli Lilly And Company | Process for the preparation of cryptophycin derivatives |
US6372936B1 (en) * | 1999-06-09 | 2002-04-16 | Eli Lilly And Company | Optical resolution of aminoisobobutyric acid |
FR2947269B1 (fr) | 2009-06-29 | 2013-01-18 | Sanofi Aventis | Nouveaux composes anticancereux |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4946835A (en) * | 1988-07-15 | 1990-08-07 | Merck & Co., Inc. | Antifungal fermentation product and method |
US4868208A (en) * | 1988-07-15 | 1989-09-19 | Merck & Co., Inc. | Antifungal agent and method |
US4845086A (en) * | 1988-08-09 | 1989-07-04 | Merck & Co., Inc. | Antifungal agent |
US4845085A (en) * | 1988-08-09 | 1989-07-04 | Merck & Co., Inc. | Antifungal agent |
DE69427706T2 (de) * | 1993-12-21 | 2001-10-25 | University Of Hawaii, Honolulu | Cryptophycine |
-
1996
- 1996-03-07 EP EP96910399A patent/EP0830136B1/en not_active Expired - Lifetime
- 1996-03-07 CN CNB96193140XA patent/CN1165337C/zh not_active Expired - Lifetime
- 1996-03-07 SK SK1199-97A patent/SK119997A3/sk unknown
- 1996-03-07 ES ES96910399T patent/ES2230561T3/es not_active Expired - Lifetime
- 1996-03-07 RO RO97-01693A patent/RO118931B1/ro unknown
- 1996-03-07 WO PCT/US1996/003246 patent/WO1996040184A1/en active IP Right Grant
- 1996-03-07 NZ NZ305571A patent/NZ305571A/xx not_active IP Right Cessation
- 1996-03-07 CZ CZ972781A patent/CZ278197A3/cs unknown
- 1996-03-07 AP APAP/P/1997/001069A patent/AP737A/en active
- 1996-03-07 AT AT96910399T patent/ATE279935T1/de not_active IP Right Cessation
- 1996-03-07 AU AU53603/96A patent/AU723652B2/en not_active Expired
- 1996-03-07 GE GEAP19963909A patent/GEP20002206B/en unknown
- 1996-03-07 MD MD97-0313A patent/MD2196B2/ro unknown
- 1996-03-07 DE DE69633667T patent/DE69633667T2/de not_active Expired - Lifetime
- 1996-03-07 PL PL96322507A patent/PL185949B1/pl unknown
- 1996-03-07 HU HU9801880A patent/HU225041B1/hu not_active IP Right Cessation
- 1996-03-07 JP JP50044097A patent/JP4181632B2/ja not_active Expired - Lifetime
- 1996-03-07 TJ TJ97000493A patent/TJ347B/xx unknown
-
1997
- 1997-09-03 FI FI973591A patent/FI973591A0/fi not_active Application Discontinuation
- 1997-09-04 BG BG101875A patent/BG63289B1/bg unknown
- 1997-09-05 NO NO19974105A patent/NO326685B1/no not_active IP Right Cessation
- 1997-09-05 OA OA70070A patent/OA10614A/en unknown
-
1998
- 1998-09-17 HK HK98110673A patent/HK1009747A1/xx not_active IP Right Cessation
Non-Patent Citations (2)
Title |
---|
CHEMICAL PHARMACEUTICAL BULLETIN, 42(10), ISSUED 1994, KOBAYASHI et al., "The Absolute Stereostructure of Arenastatin A, A Potent Cytotoxic Depsipeptide from the Okinawan Marine Sponge Dysidea Arenaria", pages 2196-2198 * |
FEBS Letters, issued 1995 KERKSIEK et al., "Interaction fo Cryptophycin 1 with Tubulin and Microtubules", pages 59-61 * |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AP737A (en) | New cryptophycins from synthesis. | |
Speicher et al. | Combined antimicrotubule activity of estramustine and taxol in human prostatic carcinoma cell lines | |
US5206018A (en) | Use of rapamycin in treatment of tumors | |
US5541232A (en) | Treatment of multidrug resistant diseases | |
US6013626A (en) | Cryptophycins from synthesis | |
CA1302270C (en) | Carcinostatic agent | |
EA006483B1 (ru) | Замещенные триазолопиримидины в качестве противораковых средств | |
NZ258044A (en) | Pharmaceutical composition comprising taxol, solubilising agent, an acid and an organic solvent | |
US20080125479A1 (en) | Wortmannin analogs and methods of using same | |
KR100459527B1 (ko) | 합성된신규한크립토파이신 | |
Hsieh et al. | Kalanchoe tubiflora extract inhibits cell proliferation by affecting the mitotic apparatus | |
CA2458318C (en) | Wortmannin analogs and methods of using same | |
CN110563743A (zh) | 一种肿瘤靶向青蒿素衍生物 | |
WO1996039829A9 (en) | New cryptophycins | |
AU2002330029A1 (en) | Wortmannin analogs and methods of using same | |
KR890017252A (ko) | 티에노트리아졸로디아제핀 화합물 및 그의 약학적 용도 | |
KR19990082064A (ko) | 피페라진 옥시란 유도체를 사용하여 신생 세포의 사멸을유도하는 방법 | |
EP1850851A2 (en) | Methods for treating cancer and other pathological proliferating disorders by inhibiting mitosis using pyrrolo[2,3-d]pyrimidines | |
AU597478B2 (en) | 3-(2-haloethyl)-1,4-oxathiins and 2-(2-haloethyl)-1,4-dithiins and treatment of leukemia and tumors therewith | |
US20030105357A1 (en) | Helianthrone derivatives as anti-cancer agents | |
RU2195458C2 (ru) | Криптофициновое соединение, фармацевтическая композиция, способ ингибирования пролиферации клеток и способ смягчения патологического состояния | |
Micheli et al. | Synthesis and Anti‐Hyperalgesic Efficacy of MP‐103, a Non‐Racemic Enantiomeric Mixture of a New 1, 4‐Diazabicyclo [4.3. 0] nonan‐9‐one | |
CA2214565C (en) | New cryptophycins from synthesis | |
RU2007176C1 (ru) | Противоопухолевое средство | |
AU2008201477A1 (en) | Wortmannin analogs and methods of using same |